A 2005 study showed that cancer patients cope better with anxiety while critically ill with shrooms. Los Angeles researchers released a study Tuesday showing that the active ingredient in shrooms, psilocybin, when given to a critically ill patient, will help them deal with the depression making it easier to deal having the whole ordeal. Drugs such as lysergic acid diethylamide that alter the mind became illegal in the 1970s which is when psychedelic drug research came to a halt. Scientists who want for making hallucinogens something that can be used clinically consider the shrooms study a milestone.
Hallucinogens make the last part of life easier
Results of the magic mushroom study were published in the Archives of General Psychiatry, a prestigious psychiatric journal. Under clinical supervision, 12 patients that had a terminal diagnosis got small doses of psilocybin, reports CNN. There was also a placebo given to a control group. The mood of patients was better when there was less anxiety after one to three months of taking psilocybin. There was a 30 percent drop in depression amongst the group after only six months. Some said that they were closer than ever with loved ones as they psilocybin gave them a different perspective on life.
Prepared research on psychedelic drugs
Researchers who conducted the magic mushroom experiment are seeking funding for more studies. ABC News talks about where psilocybin works in the brain. It works on the area that typically controls the nonverbal imagery and emotion. Magic mushroom hallucinogens are used by native cultures for centuries. Cultural and political conflict brought therapeutic analysis having psychedelic drugs to a halt in the 1970s. Dr. Charles Grob, a professor of psychiatry at Harbor-UCLA Medical Center who led the magic mushroom studies, told ABC News that “40 years later, society has reached a point where it is sufficiently mature to manage these compounds in a safe and structured manner.”.
Home not the place
The magic mushroom research, aside from offering proof that clinical use of hallucinogens can be beneficial, demonstrated that studies having psilocybin can be done safely, according to Roland Griffiths of Johns Hopkins University. Griffiths, who is conducting his own study using psilocybin, told the Los Angeles Times that the research conducted on psychedelic drugs within the 1950s and ’60s “was promising, but by no means did it reach the kinds of scientific standards that we would expect today.”. Federal and local regulators were expected to approve the experiments. That is the only reason Griffiths and Grob could do their research. The researchers discouraged cancer patients from using magic mushrooms on their own. In these studies, there was a really careful amount of doses given as to stop bad trips from happening.
Additional reading
CNN
cnn.com/2010/HEALTH/09/06/magic.mushrooms.ease.anxiety/?hpt=T2
ABC News
abcnews.go.com/Health/ucla-study-finds-magic-mushrooms-curb-anxiety-advanced/story?id=11568335
Los Angeles Times
latimes.com/news/science/la-sci-magic-mushrooms-20100907,,4230087.story?track=rss
No comments:
Post a Comment